Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

[1] Nielsen TO(2004)Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma immunohistochemical and clinical characterization of the basal- like subtype of invasive breast carcinoma Clin Cancer Res 10 5367-74

[2] Hsu FD(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-74

[3] Jensen K(2008)How basal are triple-negative breast cancers? Int J Cancer 123 236-40

[4] Cheang M(2006)Roles of cPLA2alpha and arachidonic acid in cancer Biochim Biophys Acta 1761 1335-43

[5] Karaca G(2013)Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis Oncogene 32 160-70

[6] Hu Z(2008)Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer Clin Cancer Res 14 8070-9

[7] Sørlie T(2009)Cytosolic phospholipase A2: targeting cancer through the tumor vasculature Clin Cancer Res 15 1635-44

[8] Perou CM(2012)Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer FASEB J 26 3306-20

[9] Tibshirani R(2013)Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models PLoS One 8 e69688-510

[10] Aas T(2006)Properties of the group IV phospholipase A2 family Prog Lipid Res 45 487-53

[1] Nielsen TO(2004)Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma immunohistochemical and clinical characterization of the basal- like subtype of invasive breast carcinoma Clin Cancer Res 10 5367-74

[2] Hsu FD(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-74

[3] Jensen K(2008)How basal are triple-negative breast cancers? Int J Cancer 123 236-40

[4] Cheang M(2006)Roles of cPLA2alpha and arachidonic acid in cancer Biochim Biophys Acta 1761 1335-43

[5] Karaca G(2013)Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis Oncogene 32 160-70

[6] Hu Z(2008)Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer Clin Cancer Res 14 8070-9

[7] Sørlie T(2009)Cytosolic phospholipase A2: targeting cancer through the tumor vasculature Clin Cancer Res 15 1635-44

[8] Perou CM(2012)Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer FASEB J 26 3306-20

[9] Tibshirani R(2013)Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models PLoS One 8 e69688-510

[10] Aas T(2006)Properties of the group IV phospholipase A2 family Prog Lipid Res 45 487-53